Quick Takeaways
- William D. Waddill has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,531,058.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow William D. Waddill and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Director | $3,876,262 | -$566,038 | -13% | 19 Dec 2025 |
| PTGX | Protagonist Therapeutics, Inc | Director | $654,796 | -$3,147,080 | -83% | 06 Feb 2026 |
| ANNX | Annexon, Inc. | Director | 05 Jun 2025 | |||
| TSBX | Turnstone Biologics Corp. | Director | 03 Jun 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|